INTERFERON ALFA-2B for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 190 adverse event reports in the FDA FAERS database where INTERFERON ALFA-2B was used for Malignant melanoma.
Most Reported Side Effects for INTERFERON ALFA-2B
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product use in unapproved indication | 224 | 10.8% | 20 | 18 |
| Off label use | 207 | 10.0% | 8 | 27 |
| Fatigue | 206 | 9.9% | 5 | 26 |
| Nausea | 120 | 5.8% | 4 | 20 |
| Influenza like illness | 105 | 5.1% | 0 | 8 |
| Drug ineffective | 94 | 4.5% | 7 | 10 |
| Product use issue | 86 | 4.1% | 10 | 5 |
| Headache | 80 | 3.9% | 0 | 13 |
| Pyrexia | 80 | 3.9% | 6 | 33 |
| No adverse event | 76 | 3.7% | 0 | 0 |
| Adverse event | 65 | 3.1% | 2 | 24 |
| Malaise | 62 | 3.0% | 2 | 23 |
| Death | 60 | 2.9% | 59 | 13 |
| Diarrhoea | 57 | 2.8% | 3 | 11 |
| Decreased appetite | 55 | 2.7% | 3 | 17 |
Other Indications for INTERFERON ALFA-2B
Hepatitis c (137)
Cutaneous t-cell lymphoma (83)
Mycosis fungoides (81)
Product used for unknown indication (79)
Chronic hepatitis c (77)
Bladder cancer (65)
Covid-19 (43)
Adult t-cell lymphoma/leukaemia (29)
Chronic myeloid leukaemia (29)
Neoplasm malignant (22)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)